Waters Corporation and Daiso have entered into a collaborative agreement to globally market and supply Daisogel bulk packing materials for process chromatography. The combined purification expertise of both organizations will aid pharmaceutical and biopharmaceutical companies as they move from lab-scale purifications into pilot plant and process-scale manufacturing.

To simplify scaling-up purification methods, Daisogel columns are packed using Waters patented Optimum Bed Density Technology. This OBD Technology enables analytical column performance in larger preparative columns. Scientists will save time by eliminating the need for subsequent method redevelopment as they increase in scale.

As drug manufacturers invest significant amounts of money to manufacture new drug substances, they need solid commitments from established high quality process bulk suppliers with a long track record for synthesizing chromatographic media for drug purification processes. Daiso's comprehensive quality control system is based on ISO 9001 and has met the quality requirements of global pharmaceutical companies. The company also has a Drug Master File with the US Food and Drug Administration for the Daisogel packing materials, stated company sources.

The access to gram quantity amounts or hundreds of kilograms of bulk media, contract manufacturing organizations, innovator pharmaceutical, biopharmaceutical, natural product, and generic pharmaceutical laboratories can approach Waters for the same.

Daiso provides a various range of products and technical services to such industries as pharmaceuticals, agrochemicals, electronics, machinery, textile and construction as a technology-oriented chemical company of Japan.

Providing high technology and high performance materials, Daiso contributes to global environmental conservation, industrial development and the improvement of living comfort and safety. The company has registered revenues to the tune of Japanese Yen 6.7 billion and 745 employees for the fiscal March 31, 2009.